EVMN logo

EVMN
Evommune Inc

246
Mkt Cap
$854.36M
Volume
101,602.00
52W High
$33.20
52W Low
$13.89
PE Ratio
-10.65
EVMN Fundamentals
Price
$24.42
Prev Close
$23.72
Open
$23.72
50D MA
$23.70
Beta
1.94
Avg. Volume
315,166.64
EPS (Annual)
-$2.18
P/B
3.64
Rev/Employee
$270,833.33
$392.55
Loading...
Loading...
News
all
press releases
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine
Evommune, Inc. (NYSE: EVMN) (Evommune or the Company), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced...
Business Wire·7h ago
News Placeholder
More News
News Placeholder
Capricorn Fund Managers Ltd Acquires Shares of 60,000 Evommune, Inc. $EVMN
Capricorn Fund Managers Ltd acquired a new stake in Evommune, Inc. (NYSE:EVMN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission...
MarketBeat·11h ago
News Placeholder
Evommune, Inc. (NYSE:EVMN) Receives Average Recommendation of "Buy" from Analysts
Shares of Evommune, Inc. (NYSE:EVMN - Get Free Report) have been assigned a consensus rating of "Buy" from the thirteen brokerages that are currently covering the company, Marketbeat reports. One...
MarketBeat·1d ago
News Placeholder
Evommune (NYSE:EVMN) Trading Up 10.2% - Still a Buy?
Evommune (NYSE:EVMN) Trading Up 10.2% - Here's What Happened...
MarketBeat·12d ago
News Placeholder
Evommune (NYSE:EVMN) Stock Price Down 7.6% - Should You Sell?
Evommune (NYSE:EVMN) Trading Down 7.6% - Time to Sell...
MarketBeat·13d ago
News Placeholder
Evommune (NYSE:EVMN) Upgraded at Clear Str
Clear Str upgraded Evommune to a "strong-buy" rating in a report on Tuesday...
MarketBeat·17d ago
News Placeholder
HC Wainwright Comments on Evommune's Q1 Earnings (NYSE:EVMN)
Evommune, Inc. (NYSE:EVMN - Free Report) - Research analysts at HC Wainwright dropped their Q1 2026 EPS estimates for Evommune in a report issued on Wednesday, March 18th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings of ($0.83) per share for the quarter, down fro...
MarketBeat·17d ago
News Placeholder
Analysts Set Expectations for Evommune FY2027 Earnings
Evommune, Inc. (NYSE:EVMN - Free Report) - Research analysts at HC Wainwright issued their FY2027 earnings estimates for Evommune in a report released on Wednesday, March 18th. HC Wainwright analyst M. Kapoor forecasts that the company will earn ($3.30) per share for the year. HC Wainwright has a "B...
MarketBeat·18d ago
News Placeholder
HC Wainwright Cuts Evommune (NYSE:EVMN) Price Target to $50.00
HC Wainwright decreased their target price on Evommune from $65.00 to $50.00 and set a "buy" rating for the company in a research report on Wednesday...
MarketBeat·19d ago
News Placeholder
This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Wall Street analysts have changed their outlook on top names, with new coverage and price targets. See the latest analyst ratings and opinions.read more...
Benzinga·19d ago
<
1
2
...
>

Latest EVMN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.